SEC Form 4 · accession 0001225208-18-012336
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanat Chattopadhyay
Officer — Exe V-P & Pres. MMD
Period of report
Aug 3, 2018
Accepted (ET)
Aug 6, 2018 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2018 | M | 19,208 | $33.49 | A | 70,675 | D | |
| Common Stock | Aug 3, 2018 | M | 10,000 | $37.49 | A | 80,675 | D | |
| Common StockF1 | Aug 3, 2018 | S | 29,208 | $65.20 | D | 51,467 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $37.49 | Aug 3, 2018 | M | 10,000 | D | Feb 19, 2011 | Feb 18, 2020 | Common Stock | 10,000 | 0 | D |
| Stock Option (right to buy)F3 | $33.49 | Aug 3, 2018 | M | 19,208 | D | May 7, 2011 | May 6, 2020 | Common Stock | 19,208 | 0 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2The option became exercisable in equal installments on 2/19/2011, 2/19/2012 and 2/19/2013.
- F3The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.